CClinicalTrials.gg
Sign In
Status unknownNCT02167503Updated Jun 19, 2014

Observational Study on Patients With Chronic Hepatitis B

An observational study in Chronic Hepatitis B, sponsored by Nanfang Hospital, Southern Medical University. Status unknown at 14 sites in China. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2014-06-19.

Sponsored by Nanfang Hospital, Southern Medical University · Observational

The sponsor has not verified this record recently (last verified Jun 2014), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Enrollment
10,000
Ages
30 Years and older
Sex
All
01

Study summary

The study was conducted to evaluate the effect of anti-viral treatment on long-term outcome on patients with chronic hepatitis B.

02

Conditions studied

  • Chronic Hepatitis B
03

In context

Hepatitis A

2,709 studies on the registry are indexed under Hepatitis A; 142 are open to participants now.

This study's planned enrollment of 10,000 is above the median of 250 across 687 observational studies indexed under Hepatitis A.

Browse Hepatitis A studies →

Lead sponsor

Nanfang Hospital, Southern Medical University is the lead sponsor of 480 studies on the registry; 212 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with chronic hepatitis B from hospital

Inclusion criteria

  • Male or female, aged over 30 (inclusive) years of old
  • Patients has a history of diagnosis of chronic hepatitis B (ie. HBsAg positive for more than 6 months)
  • For patients with HBsAg positive, patients should be undergoing anti-viral treatment
  • For patients with HBsAg negative, a documented evidence of previous anti-viral treatment should be provided.
  • Life expectancy is more than 1 year
  • Good treatment compliance.

Exclusion criteria

Exclusion Criteria:

  • Patients has a history of diagnosis of hepatocellular carcinoma
  • Patients with Child Pugh C
  • Coinfected with HCV, HDV and HIV
  • Suffering from other serious disease
  • Taking part in other clinical trial
05

Study design

Observational model
Cohort
Enrollment
10,000 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Cumulative rates of hepatocellular carcinoma

    Time frame: Year 5

07

Study locations

14 of 14 sites recruiting
  • Beijing Ditan Hospital
    Beijing, Beijing, China
    • Jun Cheng, MD · Contact
    • Jun Cheng, MD · Principal investigator
    Recruiting
  • Beijing Friendship Hospital Attached to the Capital Medical University
    Beijing, Beijing, China
    • Hong Ma, MD · Contact · 13651096128
    • hong ma, MD · Principal investigator
    Recruiting
  • BeiJing YouAn Hospital ,Capital Medical University
    BeiJing, Beijing, China
    • XinYue Chen, MD · Contact · 13911212398
    • XinYue Chen · Principal investigator
    Recruiting
  • Department of infectious disease, First Hospital of Peking University
    Beijing, Beijing, China
    • Yanyan Yu, MD · Contact · 13901194223
    • Yanyan Yu, MD · Principal investigator
    Recruiting
  • People's Hospital of Beijing University
    Beijing, Beijing, China
    • Lai Wei, MD · Contact
    • Lai Wei, MD · Principal investigator
    • Hao Wang, MD · Principal investigator
    Recruiting
  • Department of infectious disease, Nanfang Hospital
    Guangzhou, Guangdong 510515, China
    • Jinlin Hou, MD · Contact
    • Jinlin Hou, MD · Principal investigator
    Recruiting
  • The Third Hospital of Sun Yat-Sen University
    GuangZhou, Guangdong, China
    • ZhiLiang Gao, MD · Contact · 13902263533
    • ZhiLiang GAo · Principal investigator
    Recruiting
  • Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
    Wuhan, Hubei, China
    • Qin Ning · Contact · 13971521450
    • Qin Ning · Principal investigator
    Recruiting
  • Xiangya Hospital Central-South Univrsity
    ChangSha, Hunan, China
    • DeMing Tan, MD · Contact · 13875986817
    • DeMing Tan, MD · Principal investigator
    Recruiting
  • First Hospital .Jilin Unniversity
    ChangChun, Jilin, China
    • JunQi Niu, MD · Contact · 13756661205
    • JunQi Niu · Principal investigator
    Recruiting
  • ShengJing Hospital of China Medical University
    ShenYang, Liaoning, China
    • XiaoGuang Dou, MD · Contact · 13898867074
    • XiaoGuang Dou · Principal investigator
    Recruiting
  • Huashan Hospital，Fudan University
    ShangHai, Shanghai, China
    • GuangFeng Shi, MD · Contact · 13817780666
    • GuangFeng Shi, MD · Principal investigator
    Recruiting
  • Shanghai Ruijin Hospital
    ShangHai, Shanghai, China
    • Qing Xie, MD · Contact · 13651804273
    • Qing Xie · Principal investigator
    Recruiting
  • The First Affiliated Hospital of College of Medicine ，Zhejiang University
    HangZhou, Zhejiang, China
    • JiFang Sheng, MD · Contact · 13600519200
    • JiFang Sheng · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 19, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02167503
Lead sponsor
Nanfang Hospital, Southern Medical University
Collaborators
National Health and Family Planning Commission, P.R.China
Responsible party
Sponsor
First posted
Jun 19, 2014
Start date
May 2014
Primary completion
May 2020 (estimated)
Last update
Jun 19, 2014

Study contacts

Jinlin Hou, MD
Contact
jlhousmu@163.com
86-20-61641941
Jian Sun, MD
Contact
doctorsunjian@163.com
86-20-62787432
Jinlin Hou, MD
principal investigator · Nanfang Hospital, Southern Medical University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Hepatitis A→

Other studies from this sponsor

Nanfang Hospital, Southern Medical University

Start the discussion